Back to the Top 100

No. 87 Founders & operators

Vivek Garipalli

Co-founder and Executive Chairman, Clover HealthUnited States

Co-founder of Clover Health, a medical technology firm enhancing primary care through clinical data tools.

Find on LinkedIn

The Signal

Garipalli writes on value based care reimbursement, Medicare policy, and clinical technology incentives, sharing ideas on how aligned financial models drive healthier outcomes for high need Medicare populations in the United States.

Who Vivek Garipalli is

Co-founder of Clover Health, a medical technology firm enhancing primary care through clinical data tools.

Garipalli writes on value based care reimbursement, Medicare policy, and clinical technology incentives, sharing ideas on how aligned financial models drive healthier outcomes for high need Medicare populations in the United States.

Loading the full dossier

At a glance

Role
Co-founder and Executive Chairman
Organisation
Clover Health
Platforms
LinkedIn
Based in
United States, North America
Influence Score 84.1editorial estimate, see how it is built
Reach (25% weight)82

Audience size across LinkedIn, X, YouTube, podcasts and newsletters.

Engagement (20% weight)83

How much the audience actually reacts, comments, shares and subscribes.

Credibility (25% weight)90

Clinical, research, operating or investing track record behind the commentary.

Consistency (15% weight)76

Publishing cadence and how reliably they show up with original work.

Industry impact (15% weight)87

Whether decision makers, policy and capital actually move on what they say.

Scores are subjective editorial estimates compiled by our research desk from public profiles and published work. They are opinion, not measurement, and they are not a judgement of any person's character or ability.

Also in Founders & operators

This profile is compiled by our research desk from public sources and is published as editorial commentary. Want a correction, an update, or your profile removed? and see our corrections and removals policy.